By promoting tissue regeneration and reducing inflammation, BPC 157 can assist in improving the range of motion and reducing stiffness in the joints (Seifert et al., 2020)
Such compounded products are only available with a valid prescription from a licensed healthcare provider
We initially billed 20550 or 20551 with Q4177
Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use
The key trends to watch include: Telehealth Integration with Injection Services As telehealth continues to grow, some aspects of injection management may be coordinated remotely
